1.Expression, purification and micelle reconstruction of the transmembrane domain of the human amyloid precursor protein for NMR studies.
Xiaoyu SUN ; Xuechen ZHAO ; Wen CHEN
Chinese Journal of Biotechnology 2023;39(4):1633-1643
The multiple-step cleavage of amyloid precursor protein (APP) generates amyloid-β peptides (Aβ), highly toxic molecules causing Alzheimer's disease (AD). The nonspecific cleavage between the transmembrane region of APP (APPTM) and γ-secretase is the key step of Aβ generation. Reconstituting APPTM under physiologically-relevant conditions is crucial to investigate how it interacts with γ-secretase and for future AD drug discovery. Although producing recombinant APPTM was reported before, the large scale purification was hindered by the use of biological protease in the presence of membrane protein. Here, we expressed recombinant APPTM in Escherichia coli using the pMM-LR6 vector and recovered the fusion protein from inclusion bodies. By combining Ni-NTA chromatography, cyanogen bromide cleavage, and reverse phase high performance liquid chromatography (RP-HPLC), isotopically-labeled APPTM was obtained in high yield and high purity. The reconstitution of APPTM into dodecylphosphocholine (DPC) micelle generated mono dispersed 2D 15N-1H HSQC spectra in high quality. We successfully established an efficient and reliable method for the expression, purification and reconstruction of APPTM, which may facilitate future investigation of APPTM and its complex in more native like membrane mimetics such as bicelle and nanodiscs.
Humans
;
Amyloid beta-Protein Precursor/chemistry*
;
Micelles
;
Amyloid Precursor Protein Secretases/metabolism*
;
Magnetic Resonance Spectroscopy
;
Recombinant Proteins
2.Amyloid and Alzheimer's disease.
Protein & Cell 2010;1(4):312-314
3.beta-Secretase inhibitor increases amyloid-beta precursor protein level in rat brain cortical primary neurons induced by okadaic acid.
Chun-Jiang YU ; Wei-Zhi WANG ; Wei LIU
Chinese Medical Journal 2008;121(15):1439-1444
BACKGROUNDSenile plaques and neurofibrillary tangles (NFTs) represent two of the major histopathological hallmarks of Alzheimer's disease (AD). The plaques are primarily composed of aggregated amyloid beta (Abeta) peptides. The processing of amyloid-beta precursor protein (AbetaPP) in okadaic acid (OA)-induced tau phosphorylation primary neurons was studied.
METHODSPrimary cultures of rat brain cortical neurons were treated with OA and beta-secretase inhibitor. Neurons' viability was measured. AbetaPP processing was examined by immunocytochemistry and Western blotting with specific antibodies against the AbetaPP-N-terminus (NT) and AbetaPP-C-terminus (CT).
RESULTSTen nmol/L OA had a time-dependent suppression effect on primary neurons' viability. The suppression effect was alleviated markedly by pretreatment with beta-secretase inhibitor. After OA treatment, both AbetaPP and beta-C-terminal fragment (betaCTF) were significantly increased in neurons. AbetaPP level was increased further in neurons pretreated with beta-secretase inhibitor.
CONCLUSIONSIn OA-induced tau phosphorylation cell model, inhibition of beta-secretase may protect neurons from death induced by OA. Because of increased accumulation of AbetaPP in neurons after OA treatment, more AbetaPP turns to be cleaved by beta-secretase, producing neurotoxic betaCTF. As apotential effective therapeutic target, beta-secretase is worth investigating further.
Alzheimer Disease ; drug therapy ; Amyloid Precursor Protein Secretases ; antagonists & inhibitors ; Amyloid beta-Protein Precursor ; analysis ; Animals ; Blotting, Western ; Cell Survival ; drug effects ; Cells, Cultured ; Cerebral Cortex ; chemistry ; Enzyme Inhibitors ; pharmacology ; Immunohistochemistry ; Okadaic Acid ; pharmacology ; Peptide Fragments ; analysis ; Rats
4.Mechanism of Atractylodes macrocephala against Alzheimer's disease via regulating lysophagy based on LKB1-AMPK-TFEB pathway.
Li-Min WU ; Jie ZHAO ; Xiao-Wei ZHANG ; Zhong-Hua LI ; Pan WANG ; Yi-Ran SUN ; Zhen-Qiang ZHANG ; Zhi-Shen XIE
China Journal of Chinese Materia Medica 2022;47(17):4723-4732
Myloid beta(Aβ) is produced by cleavage of amyloid precursor protein(APP), which is a main reason for Alzheimer's disease(AD) occurrence and development. This study preliminarily investigated the mechanism of Atractylodes macrocephala(AM) against AD based on LKB1-AMPK-TFEB pathway. The effect of AM on memory ability of AD transgenic Caenorhabditis elegans CL2241 was detected, and then the APP plasmid was transiently transferred to mouse neuroblastoma(N2 a) cells in vitro. The mice were divided into the blank control group, APP group(model group), positive control group(100 μmol·L~(-1) rapamycin), and AM low-, medium-and high-dose groups(100, 200 and 300 μg·mL~(-1)). The content of Aβ_(1-42) in cell medium, the protein level of APP, the fluorescence intensity of APP, the transcriptional activity of transcription factor EB(TFEB), the activity of lysosomes in autophagy, and autophagy flux were determined by enzyme-linked immunosorbent assay(ELISA), Western blot, fluorescence microscope, luciferase reporter gene assay, RLuc-LC3 wt/RLuc-LC3 G120 A, and mRFP-GFP-LC3, respectively. The protein expression of TFEB, LC3Ⅱ, LC3Ⅰ, LAMP2, Beclin1, LKB1, p-AMPK and p-ACC was detected by Western blot. Immunofluorescence and reverse transcription-polymerase chain reaction(RT-PCR) were used to detect the fluorescence intensity of TFEB and the mRNA expression of TFEB and downstream target genes, respectively. The results showed that AM reduced the chemotactic index of transgenic C. elegans CL2241, and decreased the content of Aβ in the supernatant of cell culture medium at different concentrations. In addition, AM lowered the protein level of APP and the fluorescence intensity of APP in a dose-dependent manner. Transcriptional activity of TFEB and fluorescence intensity of mRFP-GFP-LC3 plasmid were enhanced after AM treatment, and the value of RLuc-LC3 wt/RLuc-LC3 G120 A was reduced. AM promoted the protein levels of TFEB, LAMP2 and Beclin1 at different concentrations, and increased the protein expression ratio of LC3Ⅱ/LC3Ⅰ in a dose-dependent manner. Immunofluorescence results revealed that AM improved the fluorescence intensity and nuclear expression of TFEB, and RT-PCR results indicated that AM of various concentrations elevated the mRNA expression of TFEB in APP transfected N2 a cells and promoted the transcription level of LAMP2 in a dose-dependent manner, and high-concentration AM also increased the mRNA levels of LC3 and P62. The protein levels of LKB1, p-AMPK and p-ACC were elevated by AM of different concentrations. In summary, AM regulating lysophagy and degrading APP are related to the activation of LKB1-AMPK-TFEB pathway.
AMP-Activated Protein Kinases/metabolism*
;
Alzheimer Disease/drug therapy*
;
Amyloid beta-Peptides/metabolism*
;
Amyloid beta-Protein Precursor/metabolism*
;
Animals
;
Atractylodes/chemistry*
;
Autophagy/drug effects*
;
Beclin-1/pharmacology*
;
Caenorhabditis elegans/metabolism*
;
Macroautophagy
;
Mice
;
RNA, Messenger
;
Sirolimus/pharmacology*
6.Effect of exogenous hydrogen sulfide on BACE-1 enzyme expression and β-amyloid peptide metabolism in high-glucose primary neuronal culture.
Lijuan ZHU ; Xiaoshan CHEN ; Xuanli HE ; Yunwen QI ; Yong YAN
Journal of Southern Medical University 2014;34(4):504-510
OBJECTIVETo investigate the effects of exogenous hydrogen sulfide (H2S) on β-site APP cleaving enzyme 1 (BACE-1) and β-amyloid peptide (Aβ) metabolism in primary culture of neurons under high-glucose condition.
METHODSThe cortical neurons in primary culture under normal and high glucose (60 mmol/L) conditions for 24 h were exposed to 25, 50 and 100 µmol/L NaHS. Aβ1-42 concentration in the cell culture was measured by ELISA, and BACE-1 mRNA and protein levels were detected by fluorescent quantitative real-time PCR and Western blotting, respectively.
RESULTSCompared with the neurons cultured in normal glucose, the neurons exposed to high glucose showed significantly increased Aβ1-42 concentration and BACE-1 mRNA and protein expressions (P<0.05). Exposure to 25, 50 and 100 µmol/L NaHS significantly decreased Aβ1-42 concentration and BACE-1 mRNA and protein expressions in the high-glucose cell culture (P<0.05).
CONCLUSIONNeurons exposed to high glucose exhibit increased Aβ1-42 levels and BACE-1 mRNA and protein expressions, which can be concentration-dependently decreased by NaHS.
Amyloid Precursor Protein Secretases ; metabolism ; Amyloid beta-Peptides ; metabolism ; Animals ; Aspartic Acid Endopeptidases ; metabolism ; Cells, Cultured ; Culture Media ; chemistry ; Glucose ; chemistry ; Hydrogen Sulfide ; pharmacology ; Neurons ; drug effects ; metabolism ; Peptide Fragments ; metabolism ; Rats ; Rats, Sprague-Dawley
7.Advances in research on the target antigens of antisperm antibodies.
National Journal of Andrology 2004;10(6):458-464
Antisperm antibodies can lead to immunological infertility. Further research on the target antigens of antisperm antibodies may help to discover the causal relationship of antisperm antibodies to infertility. This paper summarizes the structure and function of the six target antigens of antisperm antibodies found recently, so as to discover the causal relationship of the antibodies to infertility and provide a basis for screening a vaccine for immunological contraception.
Amyloid beta-Protein Precursor
;
chemistry
;
immunology
;
Antibodies
;
immunology
;
Antigen-Antibody Reactions
;
Cytoskeletal Proteins
;
Glycoproteins
;
chemistry
;
immunology
;
Humans
;
Infertility, Male
;
etiology
;
Male
;
Nerve Tissue Proteins
;
chemistry
;
immunology
;
Nuclear Pore Complex Proteins
;
Nuclear Proteins
;
Spermatozoa
;
immunology
;
Zyxin
8.Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase product.
Guoxin WU ; Sethu SANKARANARAYANAN ; Donna L MONTGOMERY ; Adam J SIMON ; Zhiqiang AN ; Mary J SAVAGE
Protein & Cell 2011;2(7):573-584
We have previously described a novel artificial NFEV β-secretase (BACE1) cleavage site, which when introduced into the amyloid-β precursor protein (APP), significantly enhances APP cleavage by BACE1 in in vitro and cellular assays. In this study, we describe the identification and characterization of a single chain fragment of variable region (scFv), specific to the EV neo-epitope derived from BACE1 cleavage of the NFEV-containing peptide, and its conversion to IgG1. Both the scFv displayed on phage and EV-IgG1 show exquisite specificity for binding to the EV neoepitope without cross-reactivity to other NFEV containing peptides or WT-APP KMDA cleavage products. EV-IgG1 can detect as little as 0.3 nmol/L of the EV peptide. EV-IgG1 antibody was purified, conjugated with alkaline phosphatase and utilized in various biological assays. In the BACE1 enzymatic assay using NFEV substrate, a BACE1 inhibitor MRK-3 inhibited cleavage with an IC(50) of 2.4 nmol/L with excellent reproducibility. In an APP_NFEV stable SH-SY5Y cellular assay, the EC(50) for inhibition of EV-Aβ peptide secretion with MRK-3 was 236 nmol/L, consistent with values derived using an EV polyclonal antibody. In an APP_NFEV knock-in mouse model, both Aβ_EV40 and Aβ_EV42 peptides in brain homogenate showed excellent gene dosage dependence. In conclusion, the EV neoepitope specific monoclonal antibody is a novel reagent for BACE1 inhibitor discovery for both in vitro, cellular screening assays and in vivo biochemical studies. The methods described herein are generally applicable to novel synthetic substrates and enzyme targets to enable robust screening platforms for enzyme inhibitors.
Amino Acid Sequence
;
Amyloid Precursor Protein Secretases
;
antagonists & inhibitors
;
chemistry
;
genetics
;
Amyloid beta-Protein Precursor
;
Animals
;
Antibodies
;
pharmacology
;
Brain Chemistry
;
drug effects
;
Disease Models, Animal
;
Enzyme Inhibitors
;
pharmacology
;
Enzyme-Linked Immunosorbent Assay
;
Gene Knock-In Techniques
;
Humans
;
Inhibitory Concentration 50
;
Mice
;
Molecular Sequence Data
;
Single-Chain Antibodies
;
pharmacology
9.Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands.
Wen-Chao YANG ; Qi SUN ; Ning-Xi YU ; Xiao-Lei ZHU ; Guang-Fu YANG
Acta Pharmaceutica Sinica 2012;47(3):313-321
Alzheimer's disease (AD) is a complex neurodegenerative disorder which seriously causes the dementia in elderly people and afflicts millions of people worldwide. Drug discovery for Alzheimer's disease therapy has been a hot research area and a big challenge, in which development of acetylcholinesterase (AChE) inhibitors design was the most active and some AChE inhibitors are commercially available for AD medication already. However, practical using of commercial AChE inhibitors showed their limited usefulness and related adverse effects. Thus, it is extremely urgent to find novel AChE inhibitors with higher potency and less adverse effects. Based on the accurate crystallographic studies about AChE, strategies for multi-binding site AChE inhibitors have been formed, followed by design of the multi-target directed ligands. In this review, the structures and binding modes of commercial AChE inhibitors were briefly discussed, together with the development of AChE inhibitor design for AD therapy: from multi-binding site inhibitors to multi-target directed ligands.
Acetylcholinesterase
;
chemistry
;
metabolism
;
Alzheimer Disease
;
drug therapy
;
Amyloid Precursor Protein Secretases
;
antagonists & inhibitors
;
Amyloid beta-Peptides
;
metabolism
;
Animals
;
Aspartic Acid Endopeptidases
;
antagonists & inhibitors
;
Binding Sites
;
Butyrylcholinesterase
;
chemistry
;
metabolism
;
Cholinesterase Inhibitors
;
chemical synthesis
;
chemistry
;
pharmacology
;
therapeutic use
;
Drug Design
;
Humans
;
Ligands
;
Monoamine Oxidase Inhibitors
;
chemical synthesis
;
chemistry
;
Receptors, N-Methyl-D-Aspartate
;
antagonists & inhibitors
;
Structure-Activity Relationship
10.Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia.
Jintao BAO ; Liangjun ZHENG ; Qi ZHANG ; Xinya LI ; Xuefei ZHANG ; Zeyang LI ; Xue BAI ; Zhong ZHANG ; Wei HUO ; Xuyang ZHAO ; Shujiang SHANG ; Qingsong WANG ; Chen ZHANG ; Jianguo JI
Protein & Cell 2016;7(6):417-433
Microglia play a pivotal role in clearance of Aβ by degrading them in lysosomes, countering amyloid plaque pathogenesis in Alzheimer's disease (AD). Recent evidence suggests that lysosomal dysfunction leads to insufficient elimination of toxic protein aggregates. We tested whether enhancing lysosomal function with transcription factor EB (TFEB), an essential regulator modulating lysosomal pathways, would promote Aβ clearance in microglia. Here we show that microglial expression of TFEB facilitates fibrillar Aβ (fAβ) degradation and reduces deposited amyloid plaques, which are further enhanced by deacetylation of TFEB. Using mass spectrometry analysis, we firstly confirmed acetylation as a previously unreported modification of TFEB and found that SIRT1 directly interacted with and deacetylated TFEB at lysine residue 116. Subsequently, SIRT1 overexpression enhanced lysosomal function and fAβ degradation by upregulating transcriptional levels of TFEB downstream targets, which could be inhibited when TFEB was knocked down. Furthermore, overexpression of deacetylated TFEB at K116R mutant in microglia accelerated intracellular fAβ degradation by stimulating lysosomal biogenesis and greatly reduced the deposited amyloid plaques in the brain slices of APP/PS1 transgenic mice. Our findings reveal that deacetylation of TFEB could regulate lysosomal biogenesis and fAβ degradation, making microglial activation of TFEB a possible strategy for attenuating amyloid plaque deposition in AD.
Alzheimer Disease
;
metabolism
;
pathology
;
Amyloid beta-Peptides
;
metabolism
;
Amyloid beta-Protein Precursor
;
genetics
;
metabolism
;
Animals
;
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
;
chemistry
;
genetics
;
metabolism
;
Brain
;
metabolism
;
Cells, Cultured
;
Chloride Channels
;
genetics
;
metabolism
;
Disease Models, Animal
;
HEK293 Cells
;
Humans
;
Lysosomes
;
genetics
;
metabolism
;
Mice
;
Mice, Transgenic
;
Microglia
;
cytology
;
metabolism
;
Mutagenesis, Site-Directed
;
Peptides
;
analysis
;
chemistry
;
Protein Binding
;
RNA Interference
;
Sirtuin 1
;
antagonists & inhibitors
;
genetics
;
metabolism